Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,693 | 234 | 91.9% |
| Education | $415.18 | 6 | 8.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $1,261 | 66 | $0 (2024) |
| Janssen Biotech, Inc. | $875.76 | 33 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $642.10 | 33 | $0 (2024) |
| PFIZER INC. | $315.04 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $311.72 | 12 | $0 (2024) |
| Lilly USA, LLC | $242.57 | 11 | $0 (2024) |
| SUN PHARMACEUTICAL INDUSTRIES INC. | $230.53 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $194.80 | 8 | $0 (2024) |
| Incyte Corporation | $160.66 | 8 | $0 (2024) |
| UCB, Inc. | $146.16 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,954 | 94 | Janssen Biotech, Inc. ($412.27) |
| 2023 | $1,657 | 78 | ABBVIE INC. ($545.59) |
| 2022 | $1,086 | 48 | ABBVIE INC. ($276.30) |
| 2021 | $412.03 | 20 | AbbVie Inc. ($176.34) |
All Payment Transactions
240 individual payment records from CMS Open Payments — Page 1 of 10
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $28.18 | General |
| Category: IMMUNOLOGY | ||||||
| 12/16/2024 | LEO Pharma Inc. | ADBRY (Biological) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: DERMATOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $39.02 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $19.86 | General |
| Category: Immunology | ||||||
| 12/06/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Dermatology | ||||||
| 11/20/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $17.78 | General |
| Category: Dermatology | ||||||
| 11/18/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $14.77 | General |
| Category: Immunology | ||||||
| 11/14/2024 | Organon Llc | HADLIMA (Drug) | Food and Beverage | In-kind items and services | $22.89 | General |
| Category: ADALIMUMAB-BWWD | ||||||
| 11/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.06 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/12/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Immunology | ||||||
| 11/11/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $0.28 | General |
| Category: Immunology | ||||||
| 11/05/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.79 | General |
| Category: IMMUNOLOGY | ||||||
| 11/05/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $21.45 | General |
| Category: DERMATOLOGY | ||||||
| 11/04/2024 | Lilly USA, LLC | TALTZ (Drug), EBGLYSS | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: Immunology | ||||||
| 11/01/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $12.00 | General |
| Category: Immunology | ||||||
| 10/29/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | ILUMYA (Biological) | Food and Beverage | In-kind items and services | $18.22 | General |
| Category: Dermatology | ||||||
| 10/24/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $35.53 | General |
| Category: Immunology | ||||||
| 10/23/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $29.79 | General |
| Category: Immunology | ||||||
| 10/22/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $8.50 | General |
| Category: Immunology | ||||||
| 10/21/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $29.55 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Food and Beverage | In-kind items and services | $32.15 | General |
| Category: ONCOLOGY | ||||||
| 09/26/2024 | E.R. Squibb & Sons, L.L.C. | Sotyktu (Drug) | Food and Beverage | Cash or cash equivalent | $20.18 | General |
| Category: Immunology | ||||||
| 09/12/2024 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $22.09 | General |
| Category: Dermatology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 1,092 | 1,883 | $265,925 | $62,895 |
| 2022 | 12 | 1,061 | 1,875 | $268,097 | $59,804 |
| 2021 | 14 | 613 | 1,084 | $137,729 | $32,796 |
| 2020 | 7 | 380 | 687 | $72,470 | $15,176 |
All Medicare Procedures & Services
44 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 270 | 333 | $74,925 | $16,407 | 21.9% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 128 | 160 | $40,000 | $10,941 | 27.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 87 | 116 | $37,210 | $8,510 | 22.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 192 | 226 | $33,900 | $6,899 | 20.4% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 79 | 86 | $19,780 | $4,649 | 23.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 79 | 79 | $21,725 | $4,501 | 20.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 141 | 761 | $11,415 | $3,200 | 28.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $10,660 | $2,739 | 25.7% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 21 | 25 | $5,000 | $2,594 | 51.9% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 47 | 49 | $7,350 | $1,632 | 22.2% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 22 | 22 | $3,960 | $823.39 | 20.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 230 | 287 | $64,575 | $13,674 | 21.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 89 | 120 | $38,490 | $8,406 | 21.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 107 | 129 | $32,250 | $8,131 | 25.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 108 | 108 | $29,700 | $6,115 | 20.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 105 | 114 | $26,220 | $6,067 | 23.1% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 169 | 206 | $30,900 | $5,901 | 19.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 43 | 43 | $17,630 | $3,354 | 19.0% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 128 | 769 | $11,535 | $3,136 | 27.2% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 20 | 21 | $4,200 | $2,052 | 48.9% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 23 | 35 | $4,340 | $1,072 | 24.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 27 | 30 | $4,500 | $978.54 | 21.7% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 12 | 13 | $3,757 | $917.28 | 24.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 112 | 136 | $29,250 | $6,838 | 23.4% |
| 17000 | Destruction of skin growth | Office | 2021 | 107 | 134 | $20,100 | $3,942 | 19.6% |
About Teresa George, PA
Teresa George, PA is a Physician Assistant healthcare provider based in Salem, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/29/2008. The National Provider Identifier (NPI) number assigned to this provider is 1942475918.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Teresa George, PA has received a total of $5,108 in payments from pharmaceutical and medical device companies, with $1,954 received in 2024. These payments were reported across 240 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($4,693).
As a Medicare-enrolled provider, George has provided services to 3,146 Medicare beneficiaries, totaling 5,529 services with total Medicare billing of $170,671. Data is available for 4 years (2020–2023), covering 44 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Salem, OR
- Active Since 04/29/2008
- Last Updated 04/29/2008
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1942475918
Products in Payments
- SKYRIZI (Biological) $911.18
- TREMFYA (Drug) $849.52
- Sotyktu (Drug) $642.10
- RINVOQ (Biological) $272.14
- EUCRISA (Drug) $264.24
- TALTZ (Drug) $242.57
- DUPIXENT (Biological) $242.52
- COSENTYX (Drug) $171.16
- OPZELURA (Drug) $160.66
- Bimzelx (Biological) $126.55
- Otezla (Drug) $113.46
- VTAMA (Drug) $109.00
- LIBTAYO (Biological) $108.95
- SPEVIGO (Drug) $87.89
- Odomzo (Drug) $82.21
- HUMIRA (Biological) $77.54
- ILUMYA (Biological) $52.03
- ELEKTA MEDICAL LINEAR ACCELERATOR (Device) $51.58
- CIBINQO (Drug) $50.80
- ADBRY (Biological) $43.75
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Salem
Shawn Hill, Mpas, MPAS
Physician Assistant — Payments: $16,101
Mrs. Olivia Darwin, Pa-C, PA-C
Physician Assistant — Payments: $9,122
Shannon Snyder, Pa-C, PA-C
Physician Assistant — Payments: $8,469
Eric Harmon, Pa, PA
Physician Assistant — Payments: $8,455
Robert Wollenzien
Physician Assistant — Payments: $7,551
Jordan Young, Pa-C, PA-C
Physician Assistant — Payments: $7,356